Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Besides its interest for diagnosis, the finding of an elevated serum AMH level in PCOS has open major pathophysiological issues. This review addresses the three most important issues: 1- the role of AMH in the disturbed folliculogenesis of PCOS; 2- the role of AMH in the gonadotropin dysregulation of PCOS and 3- the role of AMH in the trans-generational transmission of PCOS. For each of those issues, the clinical and experimental evidences currently available are discussed and pathophysiological hypothesis are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360 · cited 1×
“Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of childbearing age and the leading cause of hyperandrogenism (HA) and oligo-anovulation (OA) causing infertility (1).”
BackgroundSelf-citationPigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030727 · Cited by 709 · cited 4×
“First, attention has been drawn to its positive association with hyperandrogenism (HA) (7, 8), whom mechanisms are discussed in this review.”
BackgroundInfluentialDevelopmental origin of polycystic ovary syndrome—a hypothesis
Abbott, D., Dumesic, D., & Franks, S. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740001 · Cited by 504 · cited 1×
“It was in the early 2000s that the hypothesis of prenatal programming of PCOS in relation to gestational hyperandrogenism was first suggested (64).”
BackgroundCimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404
Self-citationNew Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins
Walters, K. A., Gilchrist, R. B., Ledger, W. L., Teede, H. J., Handelsman, D. J., & Campbell, R. E. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.08.005 · Cited by 186 · cited 2×
“It is secondary to the acceleration of the frequency of GnRH secretion which, for some authors, is thought to be the consequence of a negative feedback failure due to prenatal hypothalamic exposure to androgens (57).”
BackgroundMechanisms of intergenerational transmission of polycystic ovary syndrome
Dumesic, D. A., Hoyos, L. R., Chazenbalk, G. D., Naik, R., Padmanabhan, V., & Abbott, D. H. (2020) · Reproduction · doi:10.1530/rep-19-0197 · Cited by 101 · cited 2×
“Finally, recent data suggest that AMH could be involved in the epigenetic re-programming that is now believed to be the main mechanism leading to PCOS at puberty and adulthood (17).”
BackgroundOwens, L. A., Kristensen, S. G., Lerner, A., Christopoulos, G., Lavery, S., Hanyaloglu, A. C., Hardy, K., Yding Andersen, C., & Franks, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00780 · Cited by 85
The role of changing pulse frequency in the regulation of ovulation
Marshall, J. C., & Griffin, M. L. (1993) · Human Reproduction · doi:10.1093/humrep/8.suppl_2.57 · Cited by 69
Cited by
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Polycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities
Dong, J., & Rees, D. A. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000548 · Cited by 123
“30”
Shang, Y., Zhou, H., He, R., & Lu, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735954 · Cited by 61
Unraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
Metadata
- Authors
- Dewailly, D., Barbotin, A.-L., Dumont, A., Catteau-Jonard, S., & Robin, G.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-09
- Volume
- 11
- Pages
- 641-641
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3083792908
- Cited by
- 104
- References
- 8
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.3389/fendo.2020.00641
- The paper
- Dewailly, D., Barbotin, A.-L., Dumont, A., Catteau-Jonard, S., & Robin, G. (2020). Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2020.00641
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.